Supernus Pharmaceuticals
SUPN
#5037
Rank
A$2.60 B
Marketcap
A$44.65
Share price
1.78%
Change (1 day)
-36.99%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2026 (TTM): A-$1.11

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$1.14. In 2025 the company made an earnings per share (EPS) of A-$1.02 a decrease over its 2024 EPS that were of A$2.01.

EPS history for Supernus Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.118.16%
2025A-$1.02-150.75%
2024A$2.01
2022A$1.7010.78%
2021A$1.53-57.68%
2020A$3.6212.09%
2019A$3.230.47%
2018A$3.2289.38%
2017A$1.70-38.59%
2016A$2.76534.48%
2015A$0.44-211.54%
2014A-$0.39-91.1%
2013A-$4.3939.46%
2012A-$3.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.04-978.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$4.06-455.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$46.41-4,164.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.79-694.74%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
A$42.98-3,864.47%๐Ÿ‡บ๐Ÿ‡ธ USA